24.39MUSD
Type
Common Stock
Exchange
OTCQX
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
CA05475P1099
CUSIP
05475P109
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
3.25
Dividend Share
-
Dividend Yield
-
Earnings Share
-3.24
Wall Street Target Price
1.50
EPS Estimate Current Year
-1.23
EPS Estimate Next Year
-1.05
EPS Estimate Current Quarter
-0.28
EPS Estimate Next Quarter
-0.27
Most Recent Quarter
-
Revenue TTM
463,632,992
Gross Profit TTM
176,680,992
EBITDA
47,788,000
Profit Margin
-77.50%
Return On Assets TTM
-1.76%
Return On Equity TTM
-77.47%
Revenue Per Share TTM
4.183
Qtly Revenue Growth YOY
-0.80%
Diluted Eps TTM
-3.24
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
6
Price Sales TTM
0.0408
Price Book MRQ
0.0487
Enterprise Value Revenue
1
Enterprise Value EBITDA
8
16.65
3.38%131.25
0.00%41.30
0.00%14.80
0.00%31.22
0.00%142.76
-5.18%5.08
-2.03%161.60
-1.75%14.79
-0.77%29.15
-0.51%